ENST00000449132.6:c.592C>T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000449132.6(P2RX2):c.592C>T(p.Pro198Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,614,036 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P198L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000449132.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00547 AC: 832AN: 152214Hom.: 7 Cov.: 34
GnomAD3 exomes AF: 0.00180 AC: 452AN: 251254Hom.: 5 AF XY: 0.00142 AC XY: 193AN XY: 135828
GnomAD4 exome AF: 0.000789 AC: 1153AN: 1461704Hom.: 5 Cov.: 43 AF XY: 0.000704 AC XY: 512AN XY: 727164
GnomAD4 genome AF: 0.00551 AC: 839AN: 152332Hom.: 8 Cov.: 34 AF XY: 0.00572 AC XY: 426AN XY: 74488
ClinVar
Submissions by phenotype
not specified Benign:2
Asp233Asp in exon 7 of P2RX2: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 1.7% (75/4406) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs113782309). -
- -
not provided Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at